Neurological manifestations and genotype–phenotype correlations in NDUFAF6 -associated mitochondrial disease
Brain Communications · 03.03.2026 · 8 (2)
DOI: 10.1093/braincomms/fcag095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Communications, online erschienen am 18.03.2026. Verfasst von Alessandra Torraco und 23 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, National Institute for Health Research.
Abstract (Originalsprache)
NDUFAF6 encodes a mitochondrial complex I assembly factor essential for the proper biogenesis and stability of the nicotinamide adenine dinucleotide (NAD) + hydrogen (H) (NADH)–ubiquinone oxidoreductase complex. Pathogenic variants in NDUFAF6 have been increasingly recognized as a cause of mitochondrial disease, particularly Leigh syndrome, a severe neurodegenerative disorder characterized by bilateral symmetrical lesions in the central nervous system. To date, fewer than 50 patients with NDUFAF6-related mitochondrial disease have been reported, displaying a broad phenotypic spectrum ranging from early-onset neurodevelopmental regression to milder, more chronic presentations. The molecular mechanisms underlying these phenotypes are linked to impaired complex I assembly and reduced enzymatic activity, highlighting the critical role of NDUFAF6 in mitochondrial function. Here we present a cohort of 27 patients (14 males and 13 females) from 18 families harbouring biallelic variants in the NDUFAF6 gene. The patient’s mean age was 9.15 ± 8.30 years (range: 4 weeks to 25 years); 12 patients (37%) had died by the time the data were collected for this article. The clinical presentation showed wide phenotypic variability, from mild to severe psychomotor regression (74%) most commonly before the age of 5 years, hypotonia (22%), movement disorders (30%), and hypertonia (15%). Bilateral striatal necrosis lesions were the most characteristic features on cranial MRI (67%) although white matter abnormalities were also noted (15%), occasionally accompanied by cystic formations, suggestive of early neurodevelopmental anomalies. Genomic sequencing was applied, leading to the identification of 19 distinct variants in the NDUFAF6 gene, including nine novel variants not previously reported and either absent or extremely rare in public population databases. Functional studies confirmed the pathogenicity of these variants, demonstrating a deleterious effect on NDUFAF6 protein expression and a consequent impairment in complex I assembly and stability. To date, this represents the largest reported cohort of patients with NDUFAF6-associated mitochondrial disease. Our findings provide a comprehensive overview of clinical characteristics—including age of symptom onset, phenotypic variability, and patient outcomes—aiming to improve prognostic information and facilitate genetic counselling in clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.
- Mitochondrial Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
- NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, UK.
- Service de Médecine Génomique des Maladies Rares-APHP, Hôpital Necker Enfants Malades, Imagine Institute, Université Paris Cité, 75015 Paris, France.
- Division of Metabolic Diseases and Hepatology, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
- Neuromuscular Disorders Research Unit, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.
ORCID-Profile: Diego Martinelli, Stephanie Efthymiou, Barbara Siri, Nebal Waill Saadi, Henry Houlden, Agnès Rötig, Enrico Bertini, Rosalba Carrozzo
Förderung
- Wellcome Trust
- Medical Research Council
- National Institute for Health Research
- University College London Hospitals Biomedical Research Centre
- Michael J. Fox Foundation for Parkinson’s Research
- Biotechnology and Biological Sciences Research Council
- Fidelity Trust
- Rosetrees Trust
Zitieren
APA
Torraco, A., Alston, C. L., Barcia, G., Verrigni, D., Rizza, T., Di Nottia, M., Altobelli, A., Martinelli, D., Diodato, D., Efthymiou, S., Kose, M., Kriouile, Y., Lim, A. Z., Morlino, S., Siri, B., Saadi, N. W., Novelli, A., Houlden, H., Dionisi-Vici, C., …, & Carrozzo, R. (2026). Neurological manifestations and genotype–phenotype correlations in NDUFAF6 -associated mitochondrial disease. Brain Communications, 8(2). https://doi.org/10.1093/braincomms/fcag095
Vancouver
Torraco A, Alston CL, Barcia G, Verrigni D, Rizza T, Di Nottia M, et al. Neurological manifestations and genotype–phenotype correlations in NDUFAF6 -associated mitochondrial disease. Brain Communications. 2026;8(2). doi:10.1093/braincomms/fcag095
BibTeX
@article{Torraco2026,
author = {Torraco, Alessandra and Alston, Charlotte L and Barcia, Giulia and Verrigni, Daniela and Rizza, Teresa and Di Nottia, Michela and Altobelli, Anastasia and Martinelli, Diego and Diodato, Daria and Efthymiou, Stephanie and Kose, Melis and Kriouile, Yamna and Lim, Albert Z and Morlino, Silvia and Siri, Barbara and Saadi, Nebal Waill and Novelli, Antonio and Houlden, Henry and Dionisi-Vici, Carlo and McFarland, Robert and Rötig, Agnès and Bertini, Enrico and Taylor, Robert W and Carrozzo, Rosalba},
title = {Neurological manifestations and genotype–phenotype correlations in NDUFAF6 -associated mitochondrial disease},
journal = {Brain Communications},
year = {2026},
volume = {8},
number = {2},
doi = {10.1093/braincomms/fcag095}
}
EUVIMED